Skip to main content

Neurocrine Biosciences Inc

NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000914475

In the last 90 days, Neurocrine Biosciences Inc insiders filed 0 open-market purchases and 8 sales; 782 institutions reported holding it in 13F filings for Q2 2026, worth $17.0B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Neurocrine Biosciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
8 filings
6 insiders, $7.95M in total
Insiders trading
6
Net value
−$7.95M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Neurocrine Biosciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Neurocrine Biosciences Inc
NameTitleLast reported holdingLast filingFilings, past year
Onyia JudeChief Scientific Officer22,647Sep 15, 20269
Lippoldt DarinChief Legal Officer56,793Sep 15, 20267
Keswani Sanjay ChandruChief Medical Officer3,281Sep 15, 20263
Gorman Kevin CharlesDirector517,797Sep 15, 20265
Gano KyleChief Executive Officer154,728Sep 15, 20265
Delaet IngridChief Regulatory Officer18,289Sep 15, 20266
Cooke JulieChief Human Resources Officer24,025Sep 15, 20264
Boyer David W.Chief Corp. Affairs Officer8,722Sep 15, 20264
Benevich EricChief Commercial Officer67,297Sep 15, 20265
Abernethy MattChief Financial Officer42,808Sep 15, 20264
Sherwin Stephen ADirector14,860Sep 3, 20264
Norwalk Leslie VDirector2,430Jul 30, 20266
Morrow George JDirector10,386May 29, 20263
Lyons Gary ADirector122,141May 29, 20263
Pops Richard FDirector37,798May 29, 20263
Poon Christine ADirector4,753May 29, 20262
Rastetter William HDirector43,678May 29, 20263
Sharp ShaliniDirector4,088May 29, 20262
Mercier JohannaDirector6,853May 29, 20262
Roberts EiryChief Medical Officer35,640Feb 14, 20250
Lloyd-Smith MalcolmChief Integration Officer42,337Feb 8, 20230
Grigoriadis Dimitri E.Chief Research Officer82,273Feb 2, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 15, 2026 (view filing)5:03 PM ETSep 141 dayBoyer David W.Chief Corp. Affairs OfficerSSale−826$157.45−$130.1K−8.7%8.72K after10b5-1
Sep 15, 2026 (view filing)5:02 PM ETSep 141 dayAbernethy MattChief Financial OfficerSSale−2.31K$157.20−$363.3K−5.1%42.8K after10b5-1
Sep 10, 2026 (view filing)8:29 PM ETSep 91 dayBenevich EricChief Commercial OfficerSSale−2.15K$154.61−$333.0K−3.2%64.4K after10b5-1
Jul 30, 2026 (view filing)5:29 PM ETJul 282 daysNorwalk Leslie VDirectorSSale−1.25K$182.01−$227.5K−44.0%1.59K after10b5-1
Jul 13, 2026 (view filing)4:27 PM ETJul 103 daysDelaet IngridChief Regulatory OfficerSSale−4.37K$181.02−$790.5K−21.2%16.2K after10b5-1
Jul 13, 2026 (view filing)4:27 PM ETJul 94 daysLippoldt DarinChief Legal OfficerSSale−10.0K$179.60−$1.80M−15.4%54.7K after10b5-1
Jul 9, 2026 (view filing)6:41 PM ETJul 7-92 daysDelaet IngridChief Regulatory OfficerSSale−14.6K$178.65−$2.60M−47.3%16.2K after3 lots10b5-1
Jun 30, 2026 (view filing)Jun 26-294 daysLippoldt DarinChief Legal OfficerSSale−10.0K$170.15−$1.70M−15.4%54.7K after3 lots10b5-1
Jun 9, 2026 (view filing)Jun 54 daysSherwin Stephen ADirectorSSale−25.0K$165.32−$4.13M−61.2%15.9K after5 lots10b5-1
Jun 8, 2026 (view filing)Jun 44 daysNorwalk Leslie VDirectorSSale−1.25K$168.06−$210.1K−30.6%2.84K after10b5-1
Jun 4, 2026 (view filing)Jun 22 daysCooke JulieChief Human Resources OfficerSSale−36.9K$156.22−$5.77M−62.3%22.4K after5 lots10b5-1
Jun 2, 2026 (view filing)May 294 daysDelaet IngridChief Regulatory OfficerSSale−2.26K$156.71−$354.3K−12.2%16.2K after10b5-1
Jun 2, 2026 (view filing)Jun 11 dayOnyia JudeChief Scientific OfficerSSale−11.0K$160.25−$1.76M−29.9%25.8K after10b5-1
May 29, 2026 (view filing)May 272 daysOnyia JudeChief Scientific OfficerSSale−11.0K$155.53−$1.71M−29.9%25.8K after10b5-1
May 28, 2026 (view filing)May 262 daysBoyer David W.Chief Corp. Affairs OfficerSSale−3.89K$156.64−$609.0K−33.3%7.80K after10b5-1
May 21, 2026 (view filing)May 192 daysGorman Kevin CharlesDirectorSSale−245.1K$154.33−$37.8M−32.4%511.3K after10b5-1
May 18, 2026 (view filing)May 153 daysPops Richard FDirectorSSale−15.0K$157.65−$2.36M−30.3%34.5K after10b5-1
May 14, 2026 (view filing)May 122 daysNorwalk Leslie VDirectorSSale−3.81K$155.01−$590.6K−61.1%2.43K after10b5-1
Jan 20, 2026 (view filing)Jan 164 daysGano KyleChief Executive OfficerSSale−36.4K$132.70−$4.83M−20.6%140.4K after2 lots10b5-1
Dec 17, 2025 (view filing)Dec 15-162 daysNorwalk Leslie VDirectorSSale−6.19K$152.78−$945.7K−49.8%6.24K after2 lots10b5-1
Dec 10, 2025 (view filing)Dec 82 daysLippoldt DarinChief Legal OfficerSSale−4.38K$159.65−$698.6K−9.2%43.4K after10b5-1
Dec 4, 2025 (view filing)Dec 31 dayLyons Gary ADirectorSSale−15.0K$152.61−$2.29M−11.1%120.5K after10b5-1
Dec 2, 2025 (view filing)Nov 284 daysBenevich EricChief Commercial OfficerSSale−5.97K$151.74−$905.9K−11.7%44.9K afterAmended
Nov 26, 2025 (view filing)Nov 251 dayMorrow George JDirectorSSale−15.0K$143.37−$2.15M−68.0%7.07K after10b5-1
Nov 6, 2025 (view filing)Nov 51 dayRastetter William HDirectorSSale−18.0K$151.82−$2.73M−30.8%40.4K after10b5-1
Nov 4, 2025 (view filing)Nov 4Same dayGano KyleChief Executive OfficerSSale−300$141.97−$42.6K−0.2%140.4K after
Aug 11, 2025 (view filing)Aug 74 daysGorman Kevin CharlesDirectorSSale−106.3K$126.41−$13.4M−17.1%514.6K after10b5-1
Jul 11, 2025 (view filing)Jul 101 dayDelaet IngridChief Regulatory OfficerSSale−457$135.00−$61.7K−8.8%4.73K after10b5-1
Jul 11, 2025 (view filing)Jul 92 daysOnyia JudeChief Scientific OfficerSSale−59.8K$130.46−$7.80M−76.6%18.3K after10b5-1
Jul 7, 2025 (view filing)Jul 25 daysOnyia JudeChief Scientific OfficerSSale−20.4K$130.13−$2.65M−52.7%18.3K after10b5-1
May 29, 2025 (view filing)May 272 daysGorman Kevin CharlesDirectorSSale−9.61K$120.38−$1.16M−1.8%514.6K after10b5-1
May 7, 2025 (view filing)May 52 daysRastetter William HDirectorSSale−30.0K$110.20−$3.31M−44.5%37.5K after10b5-1
Feb 14, 2025 (view filing)Feb 131 dayCooke JulieChief Human Resources OfficerSSale−1.55K$116.78−$181.1K−7.1%20.2K after2 lots10b5-1
Feb 14, 2025 (view filing)Feb 131 dayGorman Kevin CharlesDirectorSSale−5.84K$116.68−$681.9K−1.1%524.2K after2 lots10b5-1
Feb 14, 2025 (view filing)Feb 131 daySherwin Stephen ADirectorSSale−13.8K$116.69−$1.61M−56.4%10.7K after10b5-1
Feb 14, 2025 (view filing)Feb 13-141 dayRoberts EiryChief Medical OfficerSSale−2.22K$116.44−$258.3K−5.9%35.6K after3 lots10b5-1
Feb 14, 2025 (view filing)Feb 131 dayOnyia JudeChief Scientific OfficerSSale−2.88K$116.79−$336.2K−13.7%18.1K after2 lots10b5-1
Feb 14, 2025 (view filing)Feb 131 dayLippoldt DarinChief Legal OfficerSSale−2.18K$116.76−$255.0K−4.8%43.4K after2 lots10b5-1
Feb 14, 2025 (view filing)Feb 131 dayGano KyleChief Executive OfficerSSale−2.56K$116.85−$298.9K−1.8%139.9K after2 lots10b5-1
Feb 14, 2025 (view filing)Feb 131 dayDelaet IngridChief Regulatory OfficerSSale−1.47K$116.71−$171.7K−23.7%4.73K after2 lots10b5-1
Feb 14, 2025 (view filing)Feb 131 dayBoyer David W.Chief Corp. Affairs OfficerSSale−1.78K$116.74−$208.4K−33.4%3.56K after2 lots10b5-1
Feb 14, 2025 (view filing)Feb 131 dayBenevich EricChief Commercial OfficerSSale−2.15K$116.73−$251.4K−4.6%44.7K after2 lots10b5-1
Feb 14, 2025 (view filing)Feb 131 dayAbernethy MattChief Financial OfficerSSale−2.56K$116.86−$298.9K−6.7%35.8K after2 lots10b5-1
Feb 12, 2025 (view filing)Feb 102 daysCooke JulieChief Human Resources OfficerSSale−700$118.28−$82.8K−3.6%18.8K after10b5-1
Feb 12, 2025 (view filing)Feb 102 daysGorman Kevin CharlesDirectorSSale−2.27K$118.37−$269.2K−0.4%519.1K after10b5-1
Feb 12, 2025 (view filing)Feb 102 daysRoberts EiryChief Medical OfficerSSale−980$118.22−$115.9K−2.9%33.3K after10b5-1
Feb 12, 2025 (view filing)Feb 102 daysLippoldt DarinChief Legal OfficerSSale−911$118.25−$107.7K−2.1%41.7K after10b5-1
Feb 12, 2025 (view filing)Feb 102 daysGano KyleChief Executive OfficerSSale−980$118.39−$116.0K−0.7%137.7K after10b5-1
Feb 12, 2025 (view filing)Feb 102 daysBoyer David W.Chief Corp. Affairs OfficerSSale−700$118.31−$82.8K−25.9%2.00K after10b5-1
Feb 12, 2025 (view filing)Feb 102 daysBenevich EricChief Commercial OfficerSSale−980$118.31−$115.9K−2.2%42.8K after10b5-1